A RISE IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY IN A PATIENT WITH SYSTEMIC VASCULITIS IN REMISSION

被引:5
|
作者
KANAME, S
UCHIDA, S
MINODA, S
ARIMURA, Y
NAGASAWA, T
ASANO, S
OGATA, E
机构
[1] UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,TOKYO 113,JAPAN
[2] KYORIN UNIV,SCH MED,DEPT INTERNAL MED 1,TOKYO,JAPAN
[3] UNIV TOKYO,FAC MED,DEPT INTERNAL MED 4,TOKYO 113,JAPAN
来源
NEPHRON | 1994年 / 68卷 / 03期
关键词
ANTINEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; CYCLOPHOSPHAMIDE; MIZORIBINE; WEGENERS GRANULOMATOSIS; NECROTIZING GLOMERULONEPHRITIS; LEUKOCYTOCLASTIC ANGIITIS; IMMUNOBLOT;
D O I
10.1159/000188405
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report a 42-year-old man who showed alveolar hemorrhage and glomerulonephritis as well as episcleritis and skin rash. He had an extremely high titer of cytoplasm-staining antineutrophil cytoplasmic antibody (C-ANCA) and was diagnosed as having systemic vasculitis based on histological findings of kidney and skin biopsies. After immunosuppressive therapy clinical manifestations resolved within several weeks and C-ANCA titers commensurably declined. C-ANCA titers, however, increased again and remained high despite clinical remission. In general, there is a close relationship between ANCA titers and clinical activities in ANCA-associated diseases, but they displayed a large discrepancy in this patient. Indeed, the serum of the patient in remission contained the antibody against 29-kD neutrophil extracts which was detected by immunoblot analysis. These findings suggest that C-ANCA may not necessarily be, by itself, pathogenetic for the development of the vasculitis.
引用
收藏
页码:380 / 384
页数:5
相关论文
共 50 条
  • [1] Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis
    Mukhtyar, C.
    Hellmich, B.
    Jayne, D.
    Flossmann, O.
    Luqmani, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (06) : S93 - S99
  • [2] Antineutrophil cytoplasmic antibody-associated vasculitis
    Konda, Raghunandan
    Rajasekaran, Arun
    Rizk, Dana V.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2024, 33 (05) : 503 - 511
  • [3] Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis
    Smith, Rona M.
    Jones, Rachel B.
    Guerry, Mary-Jane
    Laurino, Simona
    Catapano, Fausta
    Chaudhry, Afzal
    Smith, Kenneth G. C.
    Jayne, David R. W.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (11): : 3760 - 3769
  • [5] Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis
    Schmidt, Jean
    Pulido, Jose S.
    Matteson, Eric L.
    CURRENT OPINION IN OPHTHALMOLOGY, 2011, 22 (06) : 489 - 495
  • [6] Treatment of antineutrophil cytoplasmic antibody-associated vasculitis
    Rich, Eric N.
    Brown, Kevin K.
    CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (05) : 447 - 454
  • [7] Corticosteroids in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Keller, Sarah F.
    Miloslavsky, Eli M.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (01) : 91 - +
  • [8] Classification of Antineutrophil Cytoplasmic Antibody-associated Vasculitis
    Lee, Sang-Won
    Park, Yong-Beom
    JOURNAL OF RHEUMATIC DISEASES, 2019, 26 (03): : 156 - 164
  • [9] SENSITIVITY AND SPECIFICITY OF THE ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (C-ANCA) IN SYSTEMIC VASCULITIS
    HACHULLA, E
    HATRON, PY
    BROUILLARD, M
    CESBRON, JY
    REUMAUX, D
    DEVULDER, B
    REVUE DE MEDECINE INTERNE, 1994, 15 (06): : 381 - 386
  • [10] Otolaryngologic Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Nakamaru, Yuji
    Takagi, Dai
    Oridate, Nobuhiko
    Homma, Akihiro
    Fukuda, Satoshi
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2012, 146 (01) : 119 - 121